R. Lee Reinhardt

Nov 1, 2023 | healio.com | Isabella Hornick |Kristen Dowd |R. Lee Reinhardt

You've successfully added Pulmonology: Asthma to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Protection against COVID-19 from vaccination appeared reduced in patients with asthma, COPD and interstitial lung disease.

Sep 1, 2023 | openres.ersjournals.com | Anthony N. Gerber |Barry J. Make |Michael E. Wechsler |R. Lee Reinhardt

IntroductionVaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targeting the ancestral (Wuhan-Hu-1/2019) viral spike (S) protein has been broadly effective at limiting infection and severe coronavirus disease 2019 (COVID-19) [1–6]. With respect to SARS-CoV-2 infection, both the humoral and cell-mediated arms of the adaptive response are important for achieving optimal control of COVID-19 [7].